THE EFFECT OF FENOFIBRATE ON FIBRINOGEN CONCENTRATION AND BLOOD-VISCOSITY - ITS POSSIBLE CONSEQUENCES FOR MYOCARDIAL MICROCIRCULATION IN CORONARY HEART-DISEASE

被引：38

作者：

LESCHKE, M ^{[1
]}

HOFFKEN, H ^{[1
]}

SCHMIDTSDORFF, A ^{[1
]}

BLANKE, H ^{[1
]}

EGBRING, R ^{[1
]}

JOSEPH, K ^{[1
]}

STRAUER, BE ^{[1
]}

机构：

[1] UNIV MARBURG,ZENTRUM RADIOL,NUKL MED ABT,ZENTRUM INNERE MED,D-3550 MARBURG,FED REP GER

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1989年 / 114卷 / 24期

关键词：

D O I：

10.1055/s-2008-1066697

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：939 / 944

页数：6

共 36 条

[1] THE FIBRINOLYTIC SYSTEM AND COAGULATION DURING BEZAFIBRATE TREATMENT OF HYPERTRIGLYCERIDEMIA [J].

ALMER, LO ;

KJELLSTROM, T .

ATHEROSCLEROSIS, 1986, 61 (01) :81-85

[2]

[Anonymous], 1971, Br Med J, V4, P767

[3]

BOGAIEVSKY Y, 1987, DRUGS AFFECTING LIPI, P343

[4]

CHAKRABARTI R, 1968, LANCET, V2, P1007

[5] EFFECT OF CLOFIBRATE ON BLOOD-VISCOSITY IN INTERMITTENT CLAUDICATION [J].

DORMANDY, JA ;

GUTTERIDGE, JM ;

HOARE, E ;

DORMANDY, TL .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5939) :259-262

[6] CARDIOVASCULAR RISK-FACTORS AND HEMORHEOLOGY - PHYSICAL-FITNESS, STRESS AND OBESITY [J].

ERNST, E ;

WEIHMAYR, T ;

SCHMID, M ;

BAUMANN, M ;

MATRAI, A .

ATHEROSCLEROSIS, 1986, 59 (03) :263-269

[7] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[8]

GARCIA EV, 1985, J NUCL MED, V26, P17

[9]

GLUECK CJ, 1986, AM J CARDIOL, V57, P35

[10]

HOFFKEN H, 1988, J NUCL MED, V27, P16

← 1 2 3 4 →